StockData
Corcept Therapeutics Inc logo

Corcept Therapeutics Inc (CORT) stock

CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30530% above fair value
$70.07+0.85 (+1.23%)

Close on Nov 17, 2026Market cap $7.57BP/E 166.8Yield –

Corcept Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Corcept Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was 6.6%. For fiscal 2025 it was 13.1%, against 20.9% the year before. The highest annual figure on record is 81.1% in fiscal 2017.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202513.1%−7.8
FY2024Dec 31, 202420.9%−1.1
FY2023Dec 31, 202322.0%−3.2
FY2022Dec 31, 202225.2%−5.5
FY2021Dec 31, 202130.7%+0.8
FY2020Dec 31, 202030.0%−0.8
FY2019Dec 31, 201930.7%+0.7
FY2018Dec 31, 201830.0%−51.1
FY2017Dec 31, 201781.1%+71.1
FY2016Dec 31, 201610.0%+22.8
FY2015Dec 31, 2015-12.7%+105.5
FY2014Dec 31, 2014-118.2%+326.1
FY2013Dec 31, 2013-444.3%+706.3
FY2012Dec 31, 2012-1150.5%+68387.4
FY2009Dec 31, 2009-69537.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202616.8%−1.3
Q1 FY2026Mar 31, 2026-19.3%−32.3
Q4 FY2025Dec 31, 202512.0%−4.9
Q3 FY2025Sep 30, 20259.5%−16.4
Q2 FY2025Jun 30, 202518.1%−3.6
Q1 FY2025Mar 31, 202513.1%−5.8
Q4 FY2024Dec 31, 202416.9%−6.3
Q3 FY2024Sep 30, 202425.9%+0.5
Q2 FY2024Jun 30, 202421.7%−1.7
Q1 FY2024Mar 31, 202418.9%+3.9
Q4 FY2023Dec 31, 202323.2%+7.0
Q3 FY2023Sep 30, 202325.4%−8.6
Q2 FY2023Jun 30, 202323.4%−3.1
Q1 FY2023Mar 31, 202315.0%−9.3
Q4 FY2022Dec 31, 202216.1%−16.3
Q3 FY2022Sep 30, 202234.0%+2.3
Q2 FY2022Jun 30, 202226.5%−2.4
Q1 FY2022Mar 31, 202224.3%−5.2
Q4 FY2021Dec 31, 202132.4%+2.1
Q3 FY2021Sep 30, 202131.7%+6.6
Q2 FY2021Jun 30, 202129.0%−3.0
Q1 FY2021Mar 31, 202129.5%−2.7
Q4 FY2020Dec 31, 202030.3%−3.1
Q3 FY2020Sep 30, 202025.1%−7.3
Q2 FY2020Jun 30, 202032.0%+4.0
Q1 FY2020Mar 31, 202032.2%+4.1
Q4 FY2019Dec 31, 201933.4%+0.5
Q3 FY2019Sep 30, 201932.3%+4.8
Q2 FY2019Jun 30, 201927.9%−1.3
Q1 FY2019Mar 31, 201928.2%−2.1
Q4 FY2018Dec 31, 201832.9%−151.6
Q3 FY2018Sep 30, 201827.5%−4.6
Q2 FY2018Jun 30, 201829.2%−6.4
Q1 FY2018Mar 31, 201830.3%+14.4
Q4 FY2017Dec 31, 2017184.6%+165.2
Q3 FY2017Sep 30, 201732.2%+20.3
Q2 FY2017Jun 30, 201735.6%–
Q1 FY2017Mar 31, 201715.9%–
Q4 FY2016Dec 31, 201619.3%–
Q3 FY2016Sep 30, 201611.9%–

More Corcept Therapeutics figures

See a number that looks wrong?